BOOTS INTERNATIONAL LIMITED
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Drugs, Drug Proprietaries, and Druggists' Sundries), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Financial Reporting (90)
Executive Leadership Changes (67)
Earnings Reports & Warnings (63)
Stock Market Events (28)
Recruitment Activities (27)
Public Health Crisis Response (27)
Inter-Organizational Collaborations (27)
Asset Divestment (25)
Business Growth Initiatives (21)
New Product Release (19)
Economic Indicators (18)
Acquisition Announcements (17)
Workforce Reductions (15)
Tech Innovation & Advancements (14)
Business Resilience Planning (13)
Corporate Deals (12)
Business Launches (11)
IT Infrastructure Disruption (10)
Pension Fund Strategies (10)
Merger Announcements (9)
Corporate Financial Crises (9)
Employee Safety & Health (9)
Government Policy Developments (9)
Consumer Protection Measures (8)
Initial Public Offering Launch (8)
Commodity Price Fluctuations (7)
Investment Strategies (7)
Legal Proceedings (6)
Product Recall (5)
Regulatory Decisions (5)
Recent Articles about BOOTS INTERNATIONAL LIMITED
Live alerts from global media, monitored by Business Radar
2023-05-22 (insidermedia.com)
YGS to support MyHealthChecked’s Boots agreement | Business News
Manchester-based Yourgene Genomic Services (YGS) is to provide processing support for MyHealthChecked after the latter announced a retail launch at health and beauty retailer and pharmacy group Boots UK.
Read more